Page 290 - Cardiac Nursing

1
0:2
0:2
/09
/09
1
M
Pa
Pa
1 P
1 P
M
q
q
xd
66.
66.
q
6
/29
/29
xd
6
6
g
ara
a
a
t
ara
ara
In
c.
c.
a
a
In
e 2
66
66
g
g
e 2
p
p
t
A
A
p
24
p
p
5-2
5-2
24
LWBK340-c11_
LWB
LWB K34 0-c 11_ pp245-266.qxd 6/29/09 10:21 PM Page 266 Aptara Inc.
11_
0-c
K34
266 P A R T III / Assessment of Heart Disease
in-hospital mortality from ADHERE. American Journal of Cardiology, 88. Furnary, A. P., Gao, G., Grunkemeier, G. L., et al. (2003). Continuous
101, 231–237. insulin infusion reduces mortality in patient with diabetes undergoing
74. Berger, R., Huelsman, M., Strecker, K., et al. (2002). B-type natriuretic coronary artery bypass surgery. Journal of Thoracic and Cardiovascular
peptide predicts sudden death in patients with chronic heart failure. Surgery, 125, 1007–1021.
Circulation, 105, 2392–2397. 89. Malmberg, K., Ryden, L., Wedel, H., et al. (2005). Intense metabolic
75. Levitt, J. E., Vinayak, A. G., Gehlbach, B., et al. (2008). Diagnostic util- control by means of insulin in patients with diabetes mellitus and acute
ity of B-type natriuretic peptide in critically ill patients with pulmonary myocardial infarction (DIGAMI 2): Effects on mortality and morbidity.
edema: A prospective cohort study. Critical Care, 12(1), R3. European Heart Journal, 26, 650–661.
6
6
76. Colucci, W. S., & Chen, H. H. (2007). Brain natriuretic peptide meas- 90. Mehta, S. R., Yusuf, S., Diaz, R., et al. (2005). Effect of glucose-insulin-
urement in left ventricular dysfunction and other cardiac diseases. Re- potassium infusion on mortality in patients with acute ST-segment ele-
trieved April 26, 2008, from www.uptodate.com vation myocardial infarction: The CREATE-ECLA randomized con-
77. Kearon, C., Ginsberg, J. S., Douketis, J., et al. (2006). An evaluation of trolled trial. Journal of the American Medical Association, 293, 437–446.
D-dimer in the diagnosis of pulmonary embolism. Annals of Internal 91. Furnary, A. P., Zerr, K. J., Grunkemeier, G. L., et al. (1999). Continu-
4
Medicine, 144, 812–821. ous intravenous insulin infusion reduces the incidence of deep sternal
4
78. Palareti, G., Cosmi, B., Legnani, C., et al. (2006). D-dimer testing to de- wound infection in diabetic patients after cardiac surgical procedures.
7
termine the duration of anticoagulation therapy. New England Journal of Annals of Thoracic Surgery, 67, 352–360.
7
Medicine, 355, 1780–1790. 92. American Diabetes Association. (2003). Standards of medical care for
6
79. American Heart Association. (2005). Part 7.2: Management of cardiac patients with diabetes mellitus. Diabetes Care, 26(90001), 33S–50S.
6
arrest. Circulation, 112, IV-58–IV-66. 93. Rohlfing, C. L., Wiedmeyer, H. M., Little, R. R., et al. (2002). Defin-
80. Echahidi, N., Pibarot, P., O’Hara, G., et al. (2008). Mechanisms, pre- ing the relationship between plasma glucose and HbA1c: Analysis of glu-
vention, and treatment of atrial fibrillation after cardiac surgery. Journal cose profiles and HbA1c in the Diabetes Control and Complications
of the American College of Cardiology, 51, 793–801. Trial. Diabetes Care, 25(2), 275–278.
81. Miller, S., Crystal, E., Garfinkle, M., et al. (2005). Effects of magnesium on 94. American Diabetes Association. (2003). Tests of glycemia in diabetes.
atrial fibrillation after cardiac surgery: A meta analysis. Heart, 91, 618–623. Diabetes Care, 26(90001), 106S–108S.
6
6
82. Eagle, K., Guyton, R., Davidoff, R., et al. (2004). ACC/AHA 2004 95. UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive
guideline update for coronary artery bypass graft surgery: A report of the blood-glucose control with sulphonylureas or insulin compared with
American College of Cardiology/American Heart Association Task Force conventional treatment and risk of complications in patients with type
on Practice Guidelines (Committee to Update the 1999 Guidelines for 2 diabetes (UKPDS 33). Lancet, 352(9131), 837–853.
Coronary Artery Bypass Graft Surgery). Circulation, 110, e340–e437. 96. The Diabetes Control and Complications Trial Research Group. (1993).
83. LaDue, J. S., Wroblewski, F., & Karmen, A. (1954). Serum glutamic ox- The effect of intensive treatment of diabetes on the development and
aloacetic transaminase activity in human acute transmural myocardial progression of long-term complications in insulin-dependent diabetes
infarction. Science, 120, 497–499. mellitus. New England Journal of Medicine, 329(14), 977–986.
84. American Diabetes Association. (2007). Standards of medical care in 97. Wallach, J. (2007). Core blood analytes: Alterations by diseases. In In-
diabetes-2007. Diabetes Care: American Diabetes Association: Clinical terpretation of diagnostic tests. Philadelphia: Lippincott Williams &
Practice, 30, S4–S41. Wilkins.
85. Van den Berghe, G., Wouters, P., Bouillon, R., et al. (2003). Outcome 98. Beutz, M., Sherman, G., Mayfield, J., et al. (2003). Clinical utility of
benefit of intensive insulin therapy in the critically ill: Insulin dose ver- blood cultures drawn from central vein catheters and peripheral
sus glycemic control. Critical Care Medicine, 31, 359–366. venipuncture in critically ill medical patients. Chest, 123, 854–861.
86. Van den Berghe, G., Wilmer, A., Hermans, G., et al. (2006). Intensive 99. Martinez, J. A., DesJardin, J. A., Aronoff, M., et al. (2002). Clinical util-
insulin therapy in the critically ill: Insulin dose versus glycemic control. ity of blood cultures drawn from central venous or arterial catheters in
4
4
New England Journal of Medicine, 354, 449–461. critically ill surgical patients. Critical Care Medicine, 30, 7–13.
87. Zerr, K. J., Furnary, A. P., Grunkemeier, G. L., et al. (1997). Glucose 100. Wallach, J. (2007). Therapeutic drug monitoring and drug effects. In In-
control lowers the risk of wound infection in diabetes after open heart terpretation of diagnostic tests. Philadelphia: Lippincott Williams &
operations. Annals of Thoracic Surgery, 63, 356–361. Wilkins.